The Nikkei average started 47 yen higher in the afternoon session, with Mitsubishi Heavy Industries and Itochu among those rising.

[Nikkei Stock Average・TOPIX (table)] Nikkei Average: 38768.94, +47.28 TOPIX: 2720.52, +12.10 [Afternoon Opening Summary] The Nikkei average in the afternoon started slightly higher at 38,768.94 yen, up 47.28 yen from the previous day's close (38,761.02 yen). During lunchtime, the Nikkei 225 futures traded in a range of 38,730 yen to 38,840 yen. The dollar-yen exchange rate was around 155.80-90 yen per dollar from around 9:30 a.m.

Fisco JapanNov 13 22:59 ET

Volume change rate ranking (10 o'clock) ~ THECOO, Aoyama Shoji, etc. are ranked.

*In the volume change rate ranking, you can understand the interest of market participants such as trends in targeting by comparing the average volume of the last 5 days with the volume on the delivery day. ■ Top volume change rate [As of 10:32 on November 14] (Comparison with the average volume of the last 5 days) Stock code Company name Volume 5-day average volume Volume change rate Stock price change rate <4255> THECOO 1935002 198.44 367.12% 0.16 49% <8219> Aoyama

Fisco JapanNov 13 20:40 ET

Hokkaido Electric Power: Confirmatory letter.

EDINETNov 11 01:03 ET · Announcements

Hokkaido Electric Power: Semi-Annual Report - 101st Term (2024/04/01 - 2025/03/31)

EDINETNov 11 00:59 ET · Announcements

List of conversion stocks (Part 3) [List of parabolic signal conversion stocks]

○ List of buy conversion stocks Market Code Stock name Closing price SAR TSE main board <7130> Yamae Group HD 1969 1808 <7239> Tachies 1774 1726 <7246> Press Works 5545 3939 <7272> Yamaha 1354 1281 <7280> Mitsuba 8838 837 <7388> FP Partner 2955 2608 <7419> Nojima 2150 1953 <7447> Nagailebe 229

Fisco JapanOct 31 18:53 ET

Canon Inc-spons adr, 3Q operating profit increased by 14.4% to 296.6 billion yen.

Canon Inc-Spons ADR <7751> announced its third quarter financial results for the fiscal year ending December 2024, with revenue increasing by 7.3% year-on-year to 3 trillion 236.1 billion 11 million yen, operating profit increasing by 14.4% to 296.6 billion 38 million yen. The gross profit margin increased by 0.8 points from the same period last year to 47.8%, due to cost reductions and favorable product mix, with gross profit also increasing by 7.1% year-on-year to 516.4 billion yen. [Positive evaluation] Takeda Pharmaceuticals Mid-Term <4502> | <7735> S

Fisco JapanOct 31 17:22 ET